Emergent BioSolutions Inc.
EBS | NYSE
$6.55
-$0.25 (-3.68%)
At close: Sep 21, 2026, 4:00 PM ET
$6.55
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:18 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 205.4M | 99.5M | 111.7M | 642.6M | 576.3M | 621.3M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 14.2M | 18.9M | 178.1M | 171.9M | 29.9M | 82.4M |
Receivables | 84.2M | 154.5M | 191M | 159.2M | 278.9M | 230.9M |
Inventory | 343.4M | 311.7M | 328.9M | 350.7M | 344.5M | 307M |
Other Current Assets | 29.5M | 33M | 47.9M | 57.9M | 70.2M | 2.2M |
Total Current Assets | 662.5M | 598.7M | 679.5M | 1.21B | 1.27B | 1.2B |
Property-Plant & Equipment | 205.4M | 270.6M | 399M | 837M | 828.4M | 675.1M |
Goodwill & Intangibles | 436.5M | 501.5M | 566.6M | 947M | 829.5M | 929.8M |
Total Long-Term Assets | 656.1M | 791M | 1.14B | 1.96B | 1.69B | 1.69B |
Total Assets | 1.32B | 1.39B | 1.82B | 3.17B | 2.96B | 2.88B |
Account Payables | 55.6M | 60.9M | 112.2M | 103.5M | 128.9M | 136.1M |
Deferred Revenue | n/a | n/a | n/a | 26.4M | 11.7M | n/a |
Short-Term Debt | n/a | 2.7M | 413.7M | 963.1M | 37.4M | 39.5M |
Other Current Liabilities | 76.6M | 81.1M | 106.8M | 48.6M | 107.3M | 72M |
Total Current Liabilities | 132.2M | 162.4M | 651.3M | 1.23B | 374M | 384.5M |
Long-Term Debt | 572.1M | 663.7M | 446.5M | 448.5M | 809.4M | 850.3M |
Other Long-Term Liabilities | 53.9M | 29.4M | 28.9M | 26.7M | 40.6M | 173.6M |
Total Long-Term Liabilities | 663.8M | 744.5M | 522.6M | 549.7M | 972.2M | 1.05B |
Total Liabilities | 796M | 906.9M | 1.17B | 1.78B | 1.35B | 1.44B |
Total Debt | 572.1M | 676.1M | 860.2M | 1.43B | 871M | 923M |
Book Value | 522.6M | 482.8M | 649.3M | 1.39B | 1.61B | 1.45B |
Book Value Per Share | 9.22 | 9.11 | 12.68 | 27.70 | 29.79 | 26.90 |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | -159.8M | -212.4M | -21.8M | 738.7M | 950.3M | 726.9M |
Comprehensive Income | -7.5M | -5.2M | -5.7M | 3.1M | -16.1M | -25.3M |
Shareholders Equity | 522.6M | 482.8M | 649.3M | 1.39B | 1.61B | 1.45B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove EBS